[{"Assets_0_Q3_USD":191492000.0,"CommonStockSharesOutstanding_0_Q3_shares":98389000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-30624000.0,"NetIncomeLoss_3_Q3_USD":-46239000.0,"NetIncomeLoss_1_Q3_USD":-15134000.0,"StockholdersEquity_0_Q3_USD":100632000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":83570000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":79749000.0,"Ticker":"BCRX","CIK":"882796","name":"BIOCRYST PHARMACEUTICALS INC","OfficialName":"BioCryst Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1887243586.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20171108"}]